You are here: All Products

Articles

Instant access to selected ChinaBio® Today subscriber-only articles.

Browse


Viewing 1 - 15 of 3605 products
China Medical Technologies Inc. Has "No Assets" according to Liquidators
$5.00
Available
Sanjiu Medical Buys Zhongyi Pharma for $209 Million
$5.00
Available
Transcenta and Agilent Collaborate on Companion Diagnostic for Claudin18.2 mAb
$5.00
Available
Abbisko Completes Enrollment in Global Phase III Trial for Tenosynovial Giant Cell Tumor
$5.00
Available
Kelun/Merck Release Positive Early Data on TROP-2 ADC for Gastric Cancer
$5.00
Available
Kexing Biopharm’s Phase III Trial of Inhaled RSV Therapy for Children
$5.00
Available
VesiCURE Says Stem Cell Derived Extracellular Vesicles Effective in UC
$5.00
Available
Sino Biopharm to Partner China Development of Boehringer Ingelheim Portfolio
$5.00
Available
Junshi's Eighth China Approval of PD-1 is for Renal Cell Carcinoma
$5.00
Available
D3 Bio Raises $62 Million in Series A+ Round for Next-Gen KRAS G12C Inhibitor
$5.00
Available
Visen Pharma Plans Hong Kong IPO to Support Endocrine Therapies
$5.00
Available
Aurisco Pharma Expands Yangzhou CRDMO Facility for Generic GLP-1 Peptides
$5.00
Available
Insilico Medicine, an AI Drug Company, Files for Hong Kong IPO
$5.00
Available
RemeGen Granted US Fast Track for Dual-Target Candidate in Sjögren's Syndrome
$5.00
Available
ProfoundBio, a Seattle-Suzhou ADC Company, Acquired by Genmab for $1.8 Billion
$5.00
Available